Generic Spiriva Delivers First Mover Advantage In US, Lupin Plans Europe Launch

Lucentis Biosimilar Filing Seen In FY25

 
• By Vibha Ravi
  
Growth Upward Trajectory
Lupin - On A Growth Trajectory • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business